Lexaria Bioscience Corp (NAS:LEXX) Stock News, Headlines & Updates
Lexaria Bioscience Corp Stock News from GuruFocus
- 1
Aug 27, 2024
First Results from Lexaria's Second GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
Aug 22, 2024
Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
ACCESSWIRE • 11:00am
Aug 21, 2024
Positive Interim Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study
ACCESSWIRE • 11:00am
Aug 19, 2024
Positive Results from Lexaria's Molecular Characterization Study
ACCESSWIRE • 11:00am
Jul 17, 2024
Positive Interim Body Weight Results from Lexaria's Diabetes Animal Study
ACCESSWIRE • 11:00am
Jul 16, 2024
Lexaria Preparing For Strategic Growth
ACCESSWIRE • 11:00am
Jul 09, 2024
Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
Jul 08, 2024
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy
ACCESSWIRE • 11:00am
Jun 18, 2024
Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study
ACCESSWIRE • 11:00am
Jun 05, 2024
Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news